The Technical Analyst
Select Language :
Incannex Healthcare [IXHL]

Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Incannex Healthcare Price, Forecast, Insider, Ratings, Fundamentals & Signals

Incannex Healthcare is listed at the  Exchange

12.19% $3.59

America/New_York / 28 mar 2024 @ 16:00


Incannex Healthcare: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 56.97 mill
EPS: -0.880
P/E: -4.08
Earnings Date: Feb 26, 2024
SharesOutstanding: 15.87 mill
Avg Daily Volume: 0.328 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/a
Gr.Profitn/an/an/an/an/a
Ebitn/an/an/a
Asset n/an/an/an/an/an/a
Debtn/an/an/an/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -4.08 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.09x
Company: PE -4.08 | industry: PE 47.78
DISCOUNTED CASH FLOW VALUE
$0.443
(-87.65%) $-3.15
Date: 2024-03-05
Expected Trading Range (DAY)

$ 2.62 - 4.40

( +/- 25.27%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-12-21 Valentine Troy Buy 670 000 Common Stock
2023-12-21 Widdows Peter Buy 100 000 Common Stock
2023-12-21 Latham Joel Buy 1 340 000 Common Stock
2023-12-21 Anastassov George Buy 100 000 Common Stock
2023-12-21 Clark Robert Buy 100 000 Common Stock
INSIDER POWER
89.23
Last 27 transactions
Buy: 2 310 000 | Sell: 136 337

Forecast: 16:00 - $3.57

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $3.57
Forecast 2: 16:00 - $3.57
Forecast 3: 16:00 - $3.57
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $3.59 (12.19% )
Volume 0.0562 mill
Avg. Vol. 0.328 mill
% of Avg. Vol 17.13 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Incannex Healthcare Limited

Last 12 Months

Last 12 months chart data with high, low, open and close for Incannex Healthcare Limited

RSI

Intraday RSI14 chart for Incannex Healthcare Limited

Last 10 Buy & Sell Signals For IXHL

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Incannex Healthcare Limited

IXHL

Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of inflammatory lung conditions, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and bronchitis, as well as rheumatoid arthritis and inflammatory bowel diseases. It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea; and Monash Trauma Group at the Department of Neuroscience, Monash University to conduct a study on the protective effect of IHL-216A in sports concussion. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited was incorporated in 2001 and is based in Sydney, Australia.

Last 10 Buy Signals

Date Signal @
XLMUSDMar 29 - 03:38$0.140
POWRUSDMar 29 - 03:36$0.403
AMKTUSDMar 29 - 03:38219.41
CVCUSDMar 29 - 03:38$0.205
WEMIXUSDMar 29 - 03:37$2.26
TRXUSDMar 29 - 03:37$0.120
SETHUSDMar 29 - 03:303 565.05
SBDUSDMar 29 - 03:36$4.71
ROUTEUSDMar 29 - 03:374.16
MTLUSDMar 29 - 03:36$2.18

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.